Lung Function

As per available reports about 20 journals, 162 Conferences, 18 workshops are presently dedicated exclusively to Lung Function and about 2,400 articles are being published on the current trends in Lung Function. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to proteomics are being carried out. Spirometry (meaning the measuring of breath) is the most common of the pulmonary function tests (PFTs), measuring lung function, specifically the amount (volume) and/or speed (flow) of air that can be inhaled and exhaled. Spirometry is an important tool used for generating pneumotachographs, which are helpful in assessing conditions such as asthma, pulmonary fibrosis, cystic fibrosis, and COPD.

Journal of Pulmonary & Respiratory Medicine is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Lung Function. Each year research scientists have noticed a rise in the number of congresses being held in this field. Journal of Integrative Oncology provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Lung Function, thus bridging the gap between researchers and young scientists.

OMICS International – a pioneer in organizing international conferences (Cancer Science-2014 anticipating more than 300 thought provoking presentations and eminent Keynote lectures. The attending delegates from renowned organizations, Societies and Editorial Board Members of featured OMICS Group Journals. This International conference is an excellent opportunity for the participants from Universities and Institutes to interact with the World class Scientists and renowned speakers. The scientific sessions of the Cancer Science conferences housing the current research in cancer research. Tumor science will host presentations related to Tumor Microenvironment, communication, and Tumor progression. Cancer therapeutics will focus on translating cancer biology research into novel oncology treatments).